Zobrazeno 1 - 10
of 62
pro vyhledávání: '"H C Stevenson"'
Publikováno v:
Journal of Clinical Oncology. 9:2052-2066
Levamisole has been used in a wide array of clinical research and treatment settings over the past two decades, ranging from such diseases as helminthic infestations to various autoimmune diseases. Numerous preclinical evaluations and clinical trials
Publikováno v:
AIDS education and prevention : official publication of the International Society for AIDS Education. 7(2)
Video education is the most popular and effective medium for informing the adolescent population. This study investigated the impact of a culturally relevant HIV/AIDS video education. One hundred and ninety-four African-American teenagers were assign
Autor:
H C, Stevenson, J J, White
Publikováno v:
AIDS education and prevention : official publication of the International Society for AIDS Education. 6(2)
Community based AIDS prevention programming and research in minority neighborhoods are growing. The AIDS epidemic has demoralized many minority communities and has added to enormously stressing social conditions. Obstacles to effective AIDS preventio
Autor:
H C, Stevenson, G, Davis
Publikováno v:
AIDS education and prevention : official publication of the International Society for AIDS Education. 6(1)
AIDS video education is a major mode of providing information about the spread and prevention of the human immunodeficiency virus (HIV). Very little has been written about the need for culturally salient messages in increasing the acquisition and ret
Autor:
H C, Stevenson, K Y, Tsang
Publikováno v:
Immunology series. 58
Publikováno v:
Seminars in oncology. 19(6)
Interest in retinoids as therapeutic agents has developed as a result of the observations of remission induction with all-trans retinoic acid (tRA) in patients with acute promyelocytic leukemia (APL), and of high objective response rates noted with t
Autor:
J W, Clark, J W, Smith, R G, Steis, W J, Urba, E, Crum, R, Miller, J, McKnight, J, Beman, H C, Stevenson, S, Creekmore
Publikováno v:
Cancer research. 50(22)
Several groups have described the efficacy of interleukin 2 (IL-2) plus lymphokine-activated killer (LAK) cells in the treatment of cancer patients with significant response rates noted in patients with renal cell cancer and malignant melanoma; howev
Autor:
H C, Stevenson, H G, Klein
Publikováno v:
Progress in clinical and biological research. 337
Autor:
W J, Urba, R G, Steis, D L, Longo, W C, Kopp, A E, Maluish, L, Marcon, D L, Nelson, H C, Stevenson, J W, Clark
Publikováno v:
Cancer research. 50(1)
We performed a phase Ia/Ib study of interleukin 2 (IL2) in patients with cancer. Single doses of IL2 from 10(3) units/m2 to 10(7) units/m2 were well tolerated but failed to induce significant immunological changes. Chronic IL2 treatment for 5 days ou